✦ LIBER ✦

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

✍ Scribed by Jeffrey E Rubnitz; Hiroto Inaba; Gary Dahl; Raul C Ribeiro; W Paul Bowman; Jeffrey Taub; Stanley Pounds; Bassem I Razzouk; Norman J Lacayo; Xueyuan Cao; Soheil Meshinchi; Barbara Degar; Gladstone Airewele; Susana C Raimondi; Mihaela Onciu; Elaine Coustan-Smith; James R Downing; Wing Leung; Ching-Hon Pui; Dario Campana

Book ID: 117785349
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 313 KB
Volume: 11
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(10)70090-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Minimal residual disease directed therap

Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now

✍ Nick Goulden; Paul Virgo; David Grimwade 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

Clinical significance of minimal residua

Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia

✍ Rosemary Sutton; Nicola C. Venn; Jonathan Tolisano; Anita Y. Bahar; Jodie E. Gil 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Predictive value of flow cytometric mini

Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy – results from a single UK centre

✍ Jayashree Motwani; Jenny Jesson; Elaine Sturch; Sue Jones; Lisa Eyre; Phil Short 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Results of a randomized trial in childre

Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial

✍ Brenda E. S. Gibson; David K. H. Webb; Andrew J. Howman; Siebold S. N. De Graaf; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

WT1 gene expression: an excellent tool f

WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients – results from a single-centre study

✍ Mette Østergaard; Lene Hyldahl Olesen; Henrik Hasle; Eigil Kjeldsen; Peter Hokla 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

Minimal residual disease is a significan

Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993

✍ Bella Patel; Lena Rai; Georgina Buck; Sue M. Richards; Yeasmin Mortuza; Wayne Mi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB